Debiotech S.A.
http://www.debiotech.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Debiotech S.A.
Nightly Home Hemodialysis Gains First FDA Clearance
NxStage’s System One has received an expanded indication to treat patients overnight at home, which the company says improves quality of life.
NxStage Dialysis Needle Technology Gets FDA Nod
The company says its new needle technology means patients will only need to be pricked once during a dialysis procedure instead of twice which will reduce their discomfort while preserving vascular access.
News Briefs: Teleflex Acquires Vidacare; Integra Buys Covidien’s DuraSeal Line
Teleflex buys Vidacare Corp. for $262.5 million. Integra LifeSciences acquires Covidien’s Confluent Surgical product line, including the DuraSeal products, for $235 million, plus up to $30 million in milestone payments. W.L. Gore ordered to pay more than $850 million to C.R. Bard to partially resolve a long-running patent dispute. More news.
Novel Insulin Delivery Systems Pump New Life Into Diabetes Device Market
The market for insulin delivery devices is positioned to change significantly with several manufacturers gearing their products toward type 2 diabetics, who make up 90% to 95% of the diabetes patient pool in the US. These new, “pump-like” devices could offer the type 2 diabetes population better control in managing glucose levels, a solution the medical community has been seeking for a while.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
- Biomaterials
- Implantable Devices
- Surgical Equipment & Devices
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice